Back to search results

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Abroad (travel likely)RecruitingPHASE3

Conditions

Complex Regional Pain Syndrome Type I

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ambros Clinical Trial Site, Phoenix, Arizona, United States

  • Ambros Clinical Trial Site, Tucson, Arizona, United States

  • Ambros Clinical Trial Site, Napa, California, United States

  • Ambros Clinical Trial Site, Pasadena, California, United States

  • Ambros Clinical Trial Site, Tustin, California, United States

  • Ambros Clinical Trial Site, Washington D.C., District of Columbia, United States

  • Ambros Clinical Trial Site, Brandon, Florida, United States

  • Ambros Clinical Trial Site, Daytona Beach, Florida, United States

  • Ambros Clinical Trial Site, Pembroke Pines, Florida, United States

  • Ambros Clinical Trial Site, Lawrenceville, Georgia, United States

  • Ambros Clinical Trial Site, Newnan, Georgia, United States

  • Ambros Clinical Trial Site, Chicago, Illinois, United States

  • Ambros Clinical Trial Site, Orland Park, Illinois, United States

  • Ambros Clinical Trial Site, Reno, Nevada, United States

  • Ambros Clinical Trial Site, Shrewsbury, New Jersey, United States

  • Ambros Clinical Trial Site, Charlotte, North Carolina, United States

  • Ambros Clinical Trial Site, Wilmington, North Carolina, United States

  • Ambros Clinical Trial Site, Winston-Salem, North Carolina, United States

  • Ambros Clinical Trial Site, Houston, Texas, United States

View source on ClinicalTrials.gov(opens in a new tab)